Similar articles for PMID: 30287919

Year	Number of Results
2003	1
2004	1
2005	4
2007	2
2008	6
2009	1
2010	1
2011	4
2012	10
2013	6
2014	6
2015	10
2016	10
2017	13
2018	13
2019	3
2020	2
2021	4
2022	4
2023	2
2024	0

1

Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents.

Bajor M, Zych AO, Graczyk-Jarzynka A, Muchowicz A, Firczuk M, Trzeciak L, Gaj P, Domagala A, Siernicka M, Zagozdzon A, Siedlecki P, Kniotek M, O'Leary PC, Golab J, Zagozdzon R. Bajor M, et al. Br J Cancer. 2018 Oct;119(7):873-884. doi: 10.1038/s41416-018-0263-y. Epub 2018 Oct 5. Br J Cancer. 2018. PMID: 30287919 Free PMC article.

2

Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cells.

Siernicka M, Winiarska M, Bajor M, Firczuk M, Muchowicz A, Bobrowicz M, Fauriat C, Golab J, Olive D, Zagozdzon R. Siernicka M, et al. Immunology. 2015 Sep;146(1):173-83. doi: 10.1111/imm.12494. Epub 2015 Jul 8. Immunology. 2015. PMID: 26094816 Free PMC article.

3

Differential expression and function of peroxiredoxin 1 and peroxiredoxin 6 in cancerous MCF-7 and noncancerous MCF-10A breast epithelial cells.

Goncalves K, Sullivan K, Phelan S. Goncalves K, et al. Cancer Invest. 2012 Jan;30(1):38-47. doi: 10.3109/07357907.2011.629382. Cancer Invest. 2012. PMID: 22236188

4

Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer.

O'Leary PC, Terrile M, Bajor M, Gaj P, Hennessy BT, Mills GB, Zagozdzon A, O'Connor DP, Brennan DJ, Connor K, Li J, Gonzalez-Angulo AM, Sun HD, Pu JX, Pontén F, Uhlén M, Jirström K, Nowis DA, Crown JP, Zagozdzon R, Gallagher WM. O'Leary PC, et al. Breast Cancer Res. 2014 Jul 10;16(4):R79. doi: 10.1186/bcr3691. Breast Cancer Res. 2014. PMID: 25011585 Free PMC article.

5

Peroxiredoxin 1 plays a primary role in protecting pancreatic β-cells from hydrogen peroxide and peroxynitrite.

Stancill JS, Happ JT, Broniowska KA, Hogg N, Corbett JA. Stancill JS, et al. Am J Physiol Regul Integr Comp Physiol. 2020 May 1;318(5):R1004-R1013. doi: 10.1152/ajpregu.00011.2020. Epub 2020 Apr 15. Am J Physiol Regul Integr Comp Physiol. 2020. PMID: 32292063 Free PMC article.

6

Anticancer therapeutic potential of Mn porphyrin/ascorbate system.

Tovmasyan A, Sampaio RS, Boss MK, Bueno-Janice JC, Bader BH, Thomas M, Reboucas JS, Orr M, Chandler JD, Go YM, Jones DP, Venkatraman TN, Haberle S, Kyui N, Lascola CD, Dewhirst MW, Spasojevic I, Benov L, Batinic-Haberle I. Tovmasyan A, et al. Free Radic Biol Med. 2015 Dec;89:1231-47. doi: 10.1016/j.freeradbiomed.2015.10.416. Epub 2015 Oct 20. Free Radic Biol Med. 2015. PMID: 26496207 Free PMC article.

7

Expression of peroxiredoxin 1, 2, 3, and 6 genes in cancer cells during drug resistance formation.

Kalinina EV, Berezov TT, Shtil' AA, Chernov NN, Glazunova VA, Novichkova MD, Nurmuradov NK. Kalinina EV, et al. Bull Exp Biol Med. 2012 Oct;153(6):878-81. doi: 10.1007/s10517-012-1849-7. Bull Exp Biol Med. 2012. PMID: 23113308 English, Russian.

8

Pro-Apoptotic Effects of JDA-202, a Novel Natural Diterpenoid, on Esophageal Cancer Through Targeting Peroxiredoxin I.

Shi XJ, Ding L, Zhou W, Ji Y, Wang J, Wang H, Ma Y, Jiang G, Tang K, Ke Y, Zhao W, Liu HM. Shi XJ, et al. Antioxid Redox Signal. 2017 Jul 10;27(2):73-92. doi: 10.1089/ars.2016.6703. Epub 2016 Nov 1. Antioxid Redox Signal. 2017. PMID: 27650197 Free PMC article.

9

Triple Combination of Ascorbate, Menadione and the Inhibition of Peroxiredoxin-1 Produces Synergistic Cytotoxic Effects in Triple-Negative Breast Cancer Cells.

Bajor M, Graczyk-Jarzynka A, Marhelava K, Kurkowiak M, Rahman A, Aura C, Russell N, Zych AO, Firczuk M, Winiarska M, Gallagher WM, Zagozdzon R. Bajor M, et al. Antioxidants (Basel). 2020 Apr 16;9(4):320. doi: 10.3390/antiox9040320. Antioxidants (Basel). 2020. PMID: 32316111 Free PMC article.

10

PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress.

Klopotowska M, Bajor M, Graczyk-Jarzynka A, Kraft A, Pilch Z, Zhylko A, Firczuk M, Baranowska I, Lazniewski M, Plewczynski D, Goral A, Soroczynska K, Domagala J, Marhelava K, Slusarczyk A, Retecki K, Ramji K, Krawczyk M, Temples MN, Sharma B, Lachota M, Netskar H, Malmberg KJ, Zagozdzon R, Winiarska M. Klopotowska M, et al. Cancer Immunol Res. 2022 Feb;10(2):228-244. doi: 10.1158/2326-6066.CIR-20-1023. Epub 2021 Dec 1. Cancer Immunol Res. 2022. PMID: 34853030 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

85 results

Results by year